Cabazitaxel treatment in patients with metastatic castration-resistant prostate cancer (mCRPC) in daily practice - Interim analysis of the non-interventional SCOPE study

被引：0
|
作者：
Bokemeyer, C. [1 ]
Amram, M. -L. [2 ]
Stoiber, F. [3 ]
Gschwend, J. E. [4 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Dept Oncol Hematol & Bone Marrow Transplant, Hamburg, Germany
[2] Univ Hosp, Geneva, Switzerland
[3] Prov Hosp Voecklabruck, Linz, Austria
[4] Univ Hosp Rechts Isar, Munich, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / SUPPL 4期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
72
引用
收藏
页码：224 / 224
页数：1
相关论文
共 50 条
  • [1] Cabazitaxel treatment in patients with metastatic castration-resistant prostate cancer (mCRPC) in daily practice: Interim analysis of the non-interventional SCOPE study
    Bokemeyer, C.
    Amram, M-L.
    Stoiber, F.
    Gschwend, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S517 - S517
  • [2] Activity of two routine cabazitaxel treatment sequences in patients with metastatic castration-resistant prostate cancer (mCRPC) - Interim analysis of the non-interventional SCOPE study
    Bokemeyer, C.
    Otremba, B.
    Cathomas, R.
    Stoiber, F.
    Gschwend, J. E.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 47 - 47
  • [3] Cabazitaxel under routine conditions for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC): Interim results of the non-interventional SCOPE study
    Gschwend, J.
    Lange, C.
    Bokemeyer, C.
    ANNALS OF ONCOLOGY, 2018, 29
  • [4] Activity of Two Routine Cabazitaxel Treatment Sequences in Patients with Metastatic Castration- Resistant Prostate Cancer (mCRPC) - Interim Analysis of The Non-Interventional Scope Study
    Bokemeyer, Carsten
    Otremba, Burkhard
    Cathomas, Richard
    Stoiber, Franz
    Gschwend, Juergen
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 78 - 79
  • [5] Influence of the sequence of cabazitaxel therapy on the outcome of patients with metastatic castration-resistant prostate cancer - First interim results of the non-interventional SCOPE study
    Bokemeyer, C.
    Lange, C.
    Gschwend, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 76 - 77
  • [6] Non-interventional Study in metastatic, castration-resistant Prostate Cancer
    Rexer, H.
    UROLOGE, 2015, 54 (07): : 1021 - 1022
  • [7] Quality of life (QoL) in patients with metastatic castration resistant prostate cancer (mCRPC) treated with cabazitaxel: Interim analysis of a prospective non-interventional trial (QoLiTime)
    Hofheinz, R.
    Al-Batran, S. E.
    Hammerer, P.
    Kienitz, C.
    Kloss, S.
    Lange, C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S700 - S700
  • [8] Cabazitaxel for octogenarian patients with metastatic castration-resistant prostate cancer (MCRPC)
    Tralongo, P.
    Bordonaro, S.
    Di Lorenzo, G.
    Borsellino, N.
    Facchini, G.
    Rossetti, S.
    Martelli, V.
    Longo, V.
    Tralongo, A. C.
    Caspani, F.
    Tuzi, A.
    Spada, M.
    Calvani, N.
    Carlini, P.
    De Giorgi, U. F. F.
    ANNALS OF ONCOLOGY, 2019, 30
  • [9] An interim analysis of non-interventional study of the epidemiology and natural history of non-metastatic castration-resistant prostate cancer in Russia
    Alekseev, B. Ya
    Nyushko, K. M.
    Gafanov, R. A.
    Kirichek, A. A.
    Anzhiganova, Yu, V
    Kopyltsov, E., I
    Sundui, Yu Yu
    Matveev, V. B.
    ONKOUROLOGIYA, 2020, 16 (03): : 90 - 101
  • [10] Trials in progress: The influence of the therapy sequence in patients with metastatic castration resistant prostate cancer (mCRPC) treated with Cabazitaxel - the international, prospective non-interventional trial SCOPE
    Bokemeyer, C.
    Stoiber, F.
    Amram, M. -L.
    Gschwend, J. E.
    Oncology Research and Treatment, 2015, 38 : 81 - 82
12345